Disc Medicine Statistics
Total Valuation
Disc Medicine has a market cap or net worth of $3.57 billion. The enterprise value is $2.95 billion.
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Disc Medicine has 45.54 million shares outstanding. The number of shares has increased by 15.11% in one year.
| Current Share Class | 45.54M |
| Shares Outstanding | 45.54M |
| Shares Change (YoY) | +15.11% |
| Shares Change (QoQ) | +0.57% |
| Owned by Insiders (%) | 0.44% |
| Owned by Institutions (%) | 92.62% |
| Float | 40.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 539.58 |
| PB Ratio | 4.89 |
| P/TBV Ratio | 5.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.30, with a Debt / Equity ratio of 0.10.
| Current Ratio | 20.30 |
| Quick Ratio | 19.87 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -60.91 |
Financial Efficiency
Return on equity (ROE) is -41.29% and return on invested capital (ROIC) is -26.08%.
| Return on Equity (ROE) | -41.29% |
| Return on Assets (ROA) | -24.90% |
| Return on Invested Capital (ROIC) | -26.08% |
| Return on Capital Employed (ROCE) | -39.82% |
| Weighted Average Cost of Capital (WACC) | 15.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.41M |
| Employee Count | 173 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Disc Medicine has paid $317,000 in taxes.
| Income Tax | 317,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.53% in the last 52 weeks. The beta is 2.00, so Disc Medicine's price volatility has been higher than the market average.
| Beta (5Y) | 2.00 |
| 52-Week Price Change | -13.53% |
| 50-Day Moving Average | 71.56 |
| 200-Day Moving Average | 70.91 |
| Relative Strength Index (RSI) | 50.58 |
| Average Volume (20 Days) | 1,017,666 |
Short Selling Information
The latest short interest is 6.86 million, so 15.07% of the outstanding shares have been sold short.
| Short Interest | 6.86M |
| Short Previous Month | 7.46M |
| Short % of Shares Out | 15.07% |
| Short % of Float | 17.09% |
| Short Ratio (days to cover) | 4.77 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -264.88M |
| Pretax Income | -242.79M |
| Net Income | -243.10M |
| EBITDA | -264.52M |
| EBIT | -264.88M |
| Earnings Per Share (EPS) | -$6.33 |
Full Income Statement Balance Sheet
The company has $682.82 million in cash and $61.09 million in debt, with a net cash position of $621.73 million or $13.65 per share.
| Cash & Cash Equivalents | 682.82M |
| Total Debt | 61.09M |
| Net Cash | 621.73M |
| Net Cash Per Share | $13.65 |
| Equity (Book Value) | 604.25M |
| Book Value Per Share | 15.65 |
| Working Capital | 663.05M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$189.94 million and capital expenditures -$20,000, giving a free cash flow of -$189.96 million.
| Operating Cash Flow | -189.94M |
| Capital Expenditures | -20,000 |
| Depreciation & Amortization | 358,000 |
| Net Borrowing | 29.98M |
| Free Cash Flow | -189.96M |
| FCF Per Share | -$4.17 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Disc Medicine does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -15.11% |
| Shareholder Yield | -15.11% |
| Earnings Yield | -8.06% |
| FCF Yield | -5.45% |
Analyst Forecast
The average price target for Disc Medicine is $127.69, which is 62.74% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $127.69 |
| Price Target Difference | 62.74% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |